<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04811768</url>
  </required_header>
  <id_info>
    <org_study_id>Sinus-Semmelweis-Perio</org_study_id>
    <nct_id>NCT04811768</nct_id>
  </id_info>
  <brief_title>Lateral Bony Wall Repositioning in Maxillary Sinus Floor Augmentation</brief_title>
  <official_title>Comparative Clinical and Histological Investigation of Graft Integration Following Piezosurgically Retrieved Lateral Bony Wall Repositioning in Maxillary Sinus Floor Augmentation - Prospective Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Semmelweis University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NSK Europe GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Botiss Medical AG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut Straumann AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dicomlab Kft.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hungarian Human Resources Development Operational Program (EFOP-3.6.2-16-2017-00006)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Excellence Program of the Ministry for Innovation and Technology in Hungary</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Semmelweis University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present prospective randomized controlled study is to clinically and&#xD;
      histologically investigate the safety and efficacy of bony wall repositioning compared to&#xD;
      rotary window preparation with membrane coverage in maxillary sinus floor augmentation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      40 patients were randomly divided in two study groups after radiological and clinical&#xD;
      evaluation. Both groups received bone grafting by a xenogeneic bone substitute (BSM,&#xD;
      cerabone, botiss biomaterials GmbH, Zossen, Germany) using the lateral approach. In the bony&#xD;
      wall group (BW), following piezosurgery the retrieved bony wall was repositioned. In the&#xD;
      collagen membrane group (CM), the lateral window was created by rotary instruments, covered&#xD;
      via a native collagen membrane (collprotect, botiss biomaterials GmbH, Zossen, Germany).&#xD;
      After 6 months, biopsies were taken to analyze both approaches in terms of new bone&#xD;
      formation. Duration of treatment, the number of perforations, postoperative patient&#xD;
      discomfort were registered. Established histopathological analysis and histomorphometrical&#xD;
      measurements to analyze the tissue reactions and the tissue distribution, i.e., the fractions&#xD;
      of newly formed bone tissue (NB), of remaining bone substitute material (BSM) and connective&#xD;
      tissue (CT), were conducted.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Actual">May 30, 2018</completion_date>
  <primary_completion_date type="Actual">May 30, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>40 patients underwent sinus floor augmentation - 20 patients treated by bony wall repositioning, 20 patients treated by collagen membrane coverage</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Histology analysis was performed blinded, randomization sequence was revealed after histomorphometry</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of surgery</measure>
    <time_frame>During smaxillary sinus augmentation</time_frame>
    <description>Recorded in minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of lateral window preparation</measure>
    <time_frame>During maxillary sinus augmentation</time_frame>
    <description>Recorded in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mucosa preparation</measure>
    <time_frame>During maxillary sinus augmentation</time_frame>
    <description>Recorded in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale (Minimum value 0, Maximum value 100, the higher the worse)</measure>
    <time_frame>12 hours postoperatively</time_frame>
    <description>Measurement of patient discomfort</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale (Minimum value 0, Maximum value 100, the higher the worse)</measure>
    <time_frame>1 day postoperatively</time_frame>
    <description>Measurement of patient discomfort</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Edema Score</measure>
    <time_frame>2 days postoperatively</time_frame>
    <description>Measurement of swelling</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Edema Score</measure>
    <time_frame>3 days postoperatively</time_frame>
    <description>Measurement of swelling</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histomorphometrical analysis</measure>
    <time_frame>Following reentry 6 months after maxillary sinus augmentation</time_frame>
    <description>Percentage of newly formed bone, bone substitute and connective tissue</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Maxillary Sinus Augmentation</condition>
  <arm_group>
    <arm_group_label>Bony wall group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the bony wall group, following piezosurgery the retrieved bony wall was repositioned.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Collagen membrane group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the collagen membrane group, the lateral window was created by rotary instruments, covered via a native collagen membrane (collprotect, botiss biomaterials GmbH, Zossen, Germany).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Maxillary sinus augmentation</intervention_name>
    <description>The surgery was performed under local anaesthesia in both groups, lateral window preparation and window coverage was carried out based on randomization.</description>
    <arm_group_label>Bony wall group</arm_group_label>
    <arm_group_label>Collagen membrane group</arm_group_label>
    <other_name>Sinus lift</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  at least one missing maxillary premolar or molar&#xD;
&#xD;
          -  at least 7 mm crestal bone width confirmed by preoperative ConeBeam Tomography (CBCT)&#xD;
&#xD;
          -  maximally 5 mm residual bone height at the sinus floor confirmed by preoperative&#xD;
             ConeBeam Tomography (CBCT)&#xD;
&#xD;
          -  full mouth plaque and bleeding scores (FMPS and FMBS) &lt;20%&#xD;
&#xD;
          -  satisfactory patient compliance (e.g. to participate in follow-up procedures)&#xD;
&#xD;
          -  signed informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  clinically relevant diseases (e.g.: diabetes, rheumatism cancer)&#xD;
&#xD;
          -  untreated periodontitis&#xD;
&#xD;
          -  systemic steroid use&#xD;
&#xD;
          -  bisphosphonate use&#xD;
&#xD;
          -  acute or chronic inflammatory processes&#xD;
&#xD;
          -  previous endoscopic sinus surgery&#xD;
&#xD;
          -  previous sinus floor elevation&#xD;
&#xD;
          -  GBR-treatment at the study site&#xD;
&#xD;
          -  GTR-treatment at the study site&#xD;
&#xD;
          -  tooth removal within 6 weeks prior to surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Semmelweis University Department of Periodontology</name>
      <address>
        <city>Budapest</city>
        <zip>1088</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 9, 2021</study_first_submitted>
  <study_first_submitted_qc>March 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2021</study_first_posted>
  <last_update_submitted>March 19, 2021</last_update_submitted>
  <last_update_submitted_qc>March 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Semmelweis University</investigator_affiliation>
    <investigator_full_name>Balint Molnar</investigator_full_name>
    <investigator_title>Dr. Balint Molnar DMD, PhD, associate professor</investigator_title>
  </responsible_party>
  <keyword>maxillary sinus</keyword>
  <keyword>xenogeneic graft</keyword>
  <keyword>collagen membrane</keyword>
  <keyword>lateral bony wall repositioning</keyword>
  <keyword>piezoelectric surgery</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

